Trading update for six months to 30 June 18 Paris, France and Camberley, UK – 2 August 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited half year revenue update for the six months to 30 June 2018.
Visit PageCategory: NOVAPREP®
Novacyt Announces Acquisition of Infectious Disease Business from Omega Diagnostics
Acquisition of ID business from Omega Diagnostics Accelerating profitability by expanding the Lab21 business with complimentary products
Visit PageUpdate on unsecured debt facility
Update on unsecured debt facility Paris, France and Camberley, UK – 19 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of the €4.0m unsecured, anti-dilutive debt facility (the “Advance”) from a French institutional investor, into an unsecured Convertible Bond (the “Convertible Bond”) further to the
Visit Page